Burning Rock Biotech (BNR) Current Assets (2021 - 2023)

Burning Rock Biotech has reported Current Assets over the past 3 years, most recently at $122.8 million for Q4 2023.

  • Quarterly results put Current Assets at $122.8 million for Q4 2023, down 30.62% from a year ago — trailing twelve months through Dec 2023 was $122.8 million (down 30.62% YoY), and the annual figure for FY2023 was $124.5 million, down 33.58%.
  • Current Assets for Q4 2023 was $122.8 million at Burning Rock Biotech, down from $177.0 million in the prior quarter.
  • Over the last five years, Current Assets for BNR hit a ceiling of $284.8 million in Q4 2021 and a floor of $122.8 million in Q4 2023.
  • Median Current Assets over the past 3 years was $177.0 million (2022), compared with a mean of $194.9 million.
  • Biggest five-year swings in Current Assets: crashed 37.86% in 2022 and later tumbled 30.62% in 2023.
  • Burning Rock Biotech's Current Assets stood at $284.8 million in 2021, then crashed by 37.86% to $177.0 million in 2022, then plummeted by 30.62% to $122.8 million in 2023.
  • The last three reported values for Current Assets were $122.8 million (Q4 2023), $177.0 million (Q4 2022), and $284.8 million (Q4 2021) per Business Quant data.